29 employees
Zynerba Pharmaceuticals, Inc. develops pharmaceutical products via dermal solutions to treat a various neuroscience disorders
2014
$13M
from 2 investors over 2 rounds
Zynerba Pharmaceuticals raised $13M on October 14, 2014
Investors: Perceptive Advisors
Zynerba Pharmaceuticals raised undisclosed on June 15, 2007
Investors: Keyhorse Capital